-
Combined measure of inflammation, cholesterol and lipoprotein(a) predicts 30-year cardiovascular risk in women Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-17 Karina Huynh
A single combined measurement of high-sensitivity C-reactive protein, LDL-cholesterol and lipoprotein(a) levels in plasma predicts incident cardiovascular events among women over a 30-year follow-up period, according to a new study.
-
Interferon response at the border zone of the infarcted heart Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-17 Karina Huynh
Cardiomyocytes can activate the type I interferon response in the infarct border zone after myocardial infarction, indicating that the type I interferon pathway, in addition to its well-established role in antiviral responses, is also involved in cardiac injury.
-
Clonal haematopoiesis: an emerging causal risk factor for atherosclerotic CVD Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-17 Jennifer Harman
New research suggests that the presence of clonal haematopoiesis is unidirectionally associated with the development of atherosclerosis and that colchicine holds potential therapeutic value.
-
The gut microbiota in thrombosis Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-17 My Phung Khuu, Nadja Paeslack, Olga Dremova, Corinne Benakis, Klytaimnistra Kiouptsi, Christoph Reinhardt
-
Reproductive options and genetic testing for patients with an inherited cardiac disease Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-17 Job A. J. Verdonschot, Aimee D. C. Paulussen, Neal K. Lakdawala, Christine E. M. de Die-Smulders, James S. Ware, Jodie Ingles
-
Differential roles of eosinophils in cardiovascular disease Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-16 Junyan Xu, Junli Guo, Tianxiao Liu, Chongzhe Yang, Zhaojie Meng, Peter Libby, Jinying Zhang, Guo-Ping Shi
-
Diet and risk of atrial fibrillation: a systematic review Eur. Heart J. (IF 37.6) Pub Date : 2024-09-17 Monika Gawałko, Melissa E Middeldorp, Arnela Saljic, John Penders, Thomas Jespersen, Christine M Albert, Gregory M Marcus, Christopher X Wong, Prashanthan Sanders, Dominik Linz
Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia. Comprehensive modification of established AF risk factors combined with dietary interventions and breaking deleterious habits has been shown to reduce AF burden and recurrence. Numerous AF risk factors, such as diabetes, obesity or hypertension can be partially related to dietary and lifestyle choices. Therefore, dietary interventions
-
Clinical features and outcomes in carriers of pathogenic desmoplakin variants Eur. Heart J. (IF 37.6) Pub Date : 2024-09-17 Alessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, Brittney Murray, Mikael Laredo, Iris van der Schaaf, Ronald H Lekanne, Petros Syrris, Douglas Cannie, Crystal Tichnell, Chiara Cappelletto, Marta Gigli, Kristen Medo, Ardan M Saguner, Firat Duru, Nisha A Gilotra, Stefan Zimmerman, Robyn Hylind, Dominic J Abrams, Neal K Lakdawala, Julia Cadrin-Tourigny, Mattia Targetti, Iacopo Olivotto
Background and Aims Pathogenic variants in the desmoplakin (DSP) gene are associated with the development of a distinct arrhythmogenic cardiomyopathy phenotype not fully captured by either dilated cardiomyopathy (DCM), non-dilated left ventricular cardiomyopathy (NDLVC), or arrhythmogenic right ventricular cardiomyopathy (ARVC). Prior studies have described baseline DSP cardiomyopathy genetic, inflammatory
-
Activation of β3-AR by mirabegron prevents aortic dissection/aneurysm by promoting lymphangiogenesis in perivascular adipose tissue Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-17 Ze-Bei Zhang, Yu-Wen Cheng, Lian Xu, Jia-Qi Li, Xin Pan, Min Zhu, Xiao-Hui Chen, Ai-Jun Sun, Jing-Rong Lin, Ping-Jin Gao
Aims β3-AR (β3-adrenergic receptor) is essential for cardiovascular homeostasis through regulating adipose tissue function. Perivascular adipose tissue (PVAT) has been implicated in the pathogenesis of aortic dissection and aneurysm (AD/AA). Here, we aim to investigate β3-AR activation-mediated PVAT function in AD/AA. Methods and Results Aortas from patients with thoracic aortic dissection (TAD) were
-
Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-17 Alwin Tubben, George Markousis-Mavrogenis, Laura M G Meems, Bart J van Essen, Lukas Baumhove, Milou Berends, Hendrea S A Tingen, Johan Bijzet, Bouke P C Hazenberg, Adriaan A Voors, Dirk J van Veldhuisen, Riemer H J A Slart, Hans L A Nienhuis, Peter van der Meer
Aims Wild-type transthyretin cardiac amyloidosis (ATTRwt-CM) is an under-recognized aetiology of heart failure (HF), necessitating early detection for timely treatment. Our study aimed to differentiate patients with ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF patients by identifying and validating circulating protein biomarkers. In addition, we measured the same biomarkers in patients with cardiomyopathy
-
The fascinating story of lipid-lowering drugs, sodium-glucose co-transporter 2 inhibitors and GLP1-R agonists: new light shed on their beneficial effects. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-14 Filippo Crea
-
Clinical trials in-a-dish for cardiovascular medicine Eur. Heart J. (IF 37.6) Pub Date : 2024-09-14 Xuekun Wu, Kyle Swanson, Zehra Yildirim, Wenqiang Liu, Ronglih Liao, Joseph C Wu
Cardiovascular diseases persist as a global health challenge that requires methodological innovation for effective drug development. Conventional pipelines relying on animal models suffer from high failure rates due to significant interspecies variation between humans and animal models. In response, the recently enacted Food and Drug Administration Modernization Act 2.0 encourages alternative approaches
-
Abnormal circadian rhythms exacerbate dilated cardiomyopathy by reducing the ventricular mechanical strength Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-14 Hao Jia, Hao Cui, Zijie Zhao, Han Mo, Ningning Zhang, Yu Zhang, Siyuan Huang, Yue Zhang, Mengda Xu, Lei Han, Yulin Chen, Yuan Chang, Xiumeng Hua, Zhibo Shentu, Tie Xia, Xiao Chen, Jiangping Song
Aims Dilated cardiomyopathy (DCM) has etiological and pathophysiological heterogeneity. Abnormal circadian rhythm (ACR) is related to the development of DCM in animal models, but exploration based on clinical samples is lacking. Sleep apnea (SA) is the most common disease related to ACR, and we chose SA as the study object to explore ACR-DCM. Methods and results We included a derivation cohort (n =105)
-
Asymptomatic female heterozygous Fabry disease diagnosed through medical check-up. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-13 Hiroto Kawamura,Kazuto Nakamura,Akira Sato
-
Clearing up misunderstandings: addressing issues in recent cardiovascular risk review. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-13 Mina Bakhit,Paul Glasziou,Magnolia Cardona
-
Difficulties in running clinical trials on physical activity. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-13 Emmanuel A Zavalis,Pontus Andell
-
Cardiovascular disease risk communication alone is not enough: why a recent review may be misleading. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-13 Sophie Griffiths,Brian McMillan,Y Kiera Bartlett,David French
-
Re-evaluating concurrent training strategies for cardiovascular risk reduction in overweight or obese adults. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-13 Jiawei Du,Jinghua Hou
-
Olfr2+ macrophages: monocyte-derived, pro-inflammatory foamy-like cells in atherosclerosis. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-13 Clément Cochain,Alma Zernecke
-
Atheroimmunology: keeping the immune system in atherosclerosis in check Nat. Rev. Cardiol. (IF 41.7) Pub Date : 2024-09-11 Claudia Monaco, Lea Dib
-
Cyclophilin(g) a Knowledge Gap in Heart Failure Pathogenesis. Circ. Res. (IF 16.5) Pub Date : 2024-09-12 Marion Delaunay,Zegeye H Jebessa,Timothy A McKinsey
-
On the Mend: Atrial Tubulogenesis After Tachypacing-Induced Heart Failure. Circ. Res. (IF 16.5) Pub Date : 2024-09-12 Michelle L Munro,Luis A Gonano
-
Patching-Up Post-MI Hearts With Microparticle-Delivered Apelin. Circ. Res. (IF 16.5) Pub Date : 2024-09-12 Vladislav Leonov,Timothy J Kamp
-
Myeloid-Specific JAK2 Contributes to Inflammation and Salt Sensitivity of Blood Pressure. Circ. Res. (IF 16.5) Pub Date : 2024-09-12 Mohammad Saleem,Luul A Aden,Ashley Pitzer Mutchler,Chitra Basu,Lale A Ertuglu,Quanhu Sheng,Niki Penner,Anna R Hemnes,Jennifer H Park,Jeanne A Ishimwe,Cheryl L Laffer,Fernando Elijovich,Celestine N Wanjalla,Nestor de la Visitacion,Paul D Kastner,Claude F Albritton,Taseer Ahmad,Alexandria P Haynes,Justin Yu,Meghan K Graber,Sharia Yasmin,Kay-Uwe Wagner,Peter P Sayeski,Antonis K Hatzopoulos,Eric R Gamazon
BACKGROUND Salt sensitivity of blood pressure (SSBP), characterized by acute changes in blood pressure with changes in dietary sodium intake, is an independent risk factor for cardiovascular disease and mortality in people with and without hypertension. We previously found that elevated sodium concentration activates antigen-presenting cells (APCs), resulting in high blood pressure, but the mechanisms
-
Optimal Antihypertensive Systolic Blood Pressure: A Systematic Review and Meta-Analysis. Hypertension (IF 6.9) Pub Date : 2024-09-12 Paul K Whelton,Samantha O'Connell,Katherine T Mills,Jiang He
BACKGROUND Systolic blood pressure (SBP) lowering reduces major cardiovascular disease (CVD) and all-cause mortality. However, the optimal target for SBP lowering remains controversial. METHODS We included trials with random allocation to an SBP <130 mm Hg treatment target and CVD as the primary outcome. Data were extracted from each study independently and in duplicate using a standardized protocol
-
Red blood cells: a new target to prevent cardiovascular disease? Eur. Heart J. (IF 37.6) Pub Date : 2024-09-11 John Pernow,Jiangning Yang
-
The multifaceted impact of warfare on cardiovascular health. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-11 Rasha Kaddoura,Mohammed Al-Hijji
-
Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the ADMIRE Pivotal Trial. Circulation (IF 35.5) Pub Date : 2024-09-11 Vivek Y Reddy,Hugh Calkins,Moussa Mansour,Oussama Wazni,Luigi Di Biase,Marwan Bahu,David Newton,Christopher F Liu,William H Sauer,Sandeep Goyal,Vivek Iyer,Devi Nair,Charles Athill,Ayman Hussein,Patrick Whalen,Daniel Melby,Andrea Natale,
BACKGROUND Evidence from clinical trials of early pulsed field ablation (PFA) systems in treating atrial fibrillation has demonstrated their promising potential to reduce complications associated with conventional thermal modalities while maintaining efficacy. However, the lack of a fully integrated mapping system, a staple technology of most modern electrophysiology procedures, poses limitations in
-
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors JAMA Cardiol. (IF 14.8) Pub Date : 2024-09-11 Namratha R. Kandula, Nirav S. Shah, Santosh Kumar, Michael Charley, Margaret Clauson, Nicola Lancki, Emily A. Finch, Linda Ehrlich-Jones, Goutham Rao, Bonnie Spring, Nilay S. Shah, Juned Siddique
ImportanceSouth Asian adults in the US experience excess cardiovascular disease (CVD) compared with other racial and ethnic groups. The effectiveness and reach of guideline-recommended lifestyle interventions have not been evaluated in this population.ObjectiveTo evaluate whether a culturally adapted, group lifestyle intervention will improve CVD risk factors more effectively than written health education
-
On the Road to Disclose the Pathogenesis of Pericarditis-Reply. JAMA Cardiol. (IF 14.8) Pub Date : 2024-09-11 Rosa B Thorolfsdottir,Daniel F Gudbjartsson,Kari Stefansson
-
On the Road to Disclose the Pathogenesis of Pericarditis. JAMA Cardiol. (IF 14.8) Pub Date : 2024-09-11 Antonio Brucato,Humaid Almualla,Massimo Imazio
-
Addressing Lifestyle Patterns Among South Asian Individuals in the US: Implementing Meaningful Clinical Change Remains a Challenge. JAMA Cardiol. (IF 14.8) Pub Date : 2024-09-11 Anand Rohatgi,Parul Sharma,Sonia S Anand
-
Predictors for Vulnerable Plaque in Functionally Significant Lesions JACC Cardiovasc. Imaging (IF 12.8) Pub Date : 2024-09-11 Seokhun Yang MD, Doyeon Hwang MD, Koshiro Sakai MD PhD, Takuya Mizukami MD PhD, Jonathon Leipsic MD, Marta Belmonte MD, Jeroen Sonck MD PhD, Bjarne L. Nørgaard MD PhD, Hiromasa Otake MD PhD, Brian Ko MD PhD, Michael Maeng MD PhD, Jesper Møller Jensen MD PhD, Dimitri Buytaert MSc, Daniel Munhoz MD PhD, Daniele Andreini MD PhD, Hirofumi Ohashi MD PhD, Toshiro Shinke MD PhD, Charles A. Taylor PhD, Emanuele
Vulnerable plaque presents prognostic implications in addition to functional significance. The aim of this study was to identify relevant features of vulnerable plaque in functionally significant lesions. In this multicenter, prospective study conducted across 5 countries, including patients who had invasive fractional flow reserve (FFR) ≤0.80, a total of 95 patients with available pullback pressure
-
Cardiac automaticity is modulated by IKACh in sinoatrial node during pregnancy Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Valérie Long, Gracia El Gebeily, Élisabeth Leblanc, Marwa Senhadji, Céline Fiset
Aims Pregnant women have a significantly elevated resting heart rate (HR), which makes cardiac arrhythmias more likely to occur. Although electrical remodeling of the sinoatrial node (SAN) has been documented, the underlying mechanism is not fully understood. The acetylcholine-activated potassium current (IKACh), one of the major repolarizing currents in the SAN, plays a critical role in HR control
-
Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Melanie Modder, Wietse In het Panhuis, Mohan Li, Salwa Afkir, Alexandra L Dorn, Amanda C M Pronk, Trea C M Streefland, Reshma A Lalai, Stefan Pierrou, Stefan K Nilsson, Gunilla Olivecrona, Sander Kooijman, Patrick C N Rensen, Milena Schönke
Background and Aims Angiopoietin-like 3 (ANGPTL3) and 4 (ANGPTL4) inhibit lipoprotein lipase to regulate tissue fatty acid uptake from triglyceride-rich lipoproteins such as VLDL. While pharmacological inhibition of ANGPTL3 is being evaluated as lipid-lowering strategy, systemic ANGPTL4 inhibition is not pursued due to adverse effects. This study aimed to compare the therapeutic potential of liver-specific
-
When bigger is better: utilizing large animal models in vein graft surgery to gain insights into endothelial-to-mesenchymal transition. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Clarissa Becher,Marie Jose Goumans,Gonzalo Sanchez-Duffhues
-
Uncovering vascular signature of sphingosine-1-phosphate receptor 1 activation. Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-11 Ewelina Józefczuk,Mateusz Siedlinski
-
Tackling difficult clinical scenarios on cardiovascular disease in the peripartum period: meeting reports from Pregnancy and the Heart Symposia in Cape Town and Mauritius. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-10 Blanche Cupido,Sanjay Bucktowar,Karen Sliwa
-
What is the role of sex and gender in the future of precision cardiology? Eur. Heart J. (IF 37.6) Pub Date : 2024-09-10 Stefano Ministrini,Teresa Padró
-
Cardio-oncology 2023: insights from the National Societies of Cardiology Journals of the European Society of Cardiology. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-10 Jean-Jacques Monsuez,Plamen Gatzov,Fernando Alfonso,
-
Promoting a healthier Ramadan: addressing mind, body, soul, and heart wellbeing. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-10 Mohammed Y Khanji,Waheeb Al-Azzani,Shams Abdalla,Salman Waqar
-
Integration of a hypertension treatment programme into Nigeria's primary healthcare system: report from a stakeholders and policymakers' workshop. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-10 Chisom Obiezu-Umeh,Mark D Huffman,Dike B Ojji
-
IRS2 Signaling Protects Against Stress-Induced Arrhythmia by Maintaining Ca2+ Homeostasis. Circulation (IF 35.5) Pub Date : 2024-09-10 Qian Shi,Jinxi Wang,Hamza Malik,Xuguang Li,Jennifer Streeter,Jacob Sharafuddin,Eric Weatherford,David Stein,Yuval Itan,Biyi Chen,Duane Hall,Long-Sheng Song,E Dale Abel
BACKGROUND The docking protein IRS2 (insulin receptor substrate protein-2) is an important mediator of insulin signaling and may also regulate other signaling pathways. Murine hearts with cardiomyocyte-restricted deletion of IRS2 (cIRS2-KO) are more susceptible to pressure overload-induced cardiac dysfunction, implying a critical protective role of IRS2 in cardiac adaptation to stress through mechanisms
-
Glucosamine-Mediated Hexosamine Biosynthesis Pathway Activation Uses ATF4 to Promote "Exercise-Like" Angiogenesis and Perfusion Recovery in PAD. Circulation (IF 35.5) Pub Date : 2024-09-10 Suhib Alhusban,Mohamed Nofal,Anita Kovacs-Kasa,Taylor C Kress,M Murat Koseoglu,Abdelrahman A Zaied,Eric J Belin de Chantemele,Brian H Annex
BACKGROUND Endothelial cells (ECs) use glycolysis to produce energy. In preclinical models of peripheral arterial disease, further activation of EC glycolysis was ineffective or deleterious in promoting hypoxia-dependent angiogenesis, whereas pentose phosphate pathway activation was effective. Hexosamine biosynthesis pathway, pentose phosphate pathway, and glycolysis are closely linked. Glucosamine
-
Evaluation and Management of Kidney Dysfunction in Advanced Heart Failure: A Scientific Statement From the American Heart Association. Circulation (IF 35.5) Pub Date : 2024-09-10 W H Wilson Tang,Marie A Bakitas,Xingxing S Cheng,James C Fang,Savitri E Fedson,Amy G Fiedler,Pieter Martens,Wendy I McCallum,Modele O Ogunniyi,Janani Rangaswami,Nisha Bansal,
Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. In addition to elevations in serum creatinine, kidney dysfunction encompasses inadequate maintenance of sodium and volume homeostasis, retention of uremic solutes, and disrupted endocrine functions. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to
-
Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans. Circulation (IF 35.5) Pub Date : 2024-09-10 Jonas Henrik Kristensen,Rasmus Bo Hasselbalch,Nina Strandkjær,Nicoline Jørgensen,Morten Østergaard,Peter Hasse Møller-Sørensen,Jens Christian Nilsson,Shoaib Afzal,Pia Rørbæk Kamstrup,Morten Dahl,Mustafa Vakur Bor,Ruth Frikke-Schmidt,Niklas Rye Jørgensen,Line Rode,Lene Holmvang,Jesper Kjærgaard,Lia Evi Bang,Julie Forman,Kim Dalhoff,Allan S Jaffe,Kristian Thygesen,Henning Bundgaard,Kasper Karmark Iversen
BACKGROUND Cardiac troponin (cTn) is key in diagnosing myocardial infarction (MI). After MI, the clinically observed half-life of cTn has been reported to be 7 to 20 hours, but this estimate reflects the combined elimination and simultaneous release of cTn from cardiomyocytes. More precise timing of myocardial injuries necessitates separation of these 2 components. We used a novel method for determination
-
Endothelial estrogen - myocardial cGMP axis critically determines angiogenesis and cardiac performance during pressure-overload Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-10 Nobuaki Fukuma, Hiroyuki Tokiwa, Genri Numata, Kazutaka Ueda, Pangyen Liu, Miyu Tajima, Yu Otsu, Taro Kariya, Yukio Hiroi, James K Liao, Issei Komuro, Eiki Takimoto
Aim Estrogen exerts beneficial cardiovascular effects by binding to specific receptors on various cells to activate nuclear and non-nuclear actions. Estrogen receptor α (ERα) non-nuclear signaling confers protection against heart failure remodeling, involving myocardial cyclic guanosine monophosphate (cGMP) - cGMP-dependent protein kinase G (PKG) activation; however, its tissue-specific role remains
-
Smad1/5 is acetylated in the dorsal aortae of the mouse embryo before the onset of blood flow, driving early arterial gene expression Cardiovasc. Res. (IF 10.2) Pub Date : 2024-09-10 Margo Daems, Ljuba C Ponomarev, Rita Simoes-Faria, Max Nobis, Colinda L G J Scheele, Aernout Luttun, Bart Ghesquière, An Zwijsen, Elizabeth A V Jones
Aims During embryonic development, arteriovenous (AV) differentiation ensures proper blood vessel formation and maturation. Defects in arterial or venous identity cause inappropriate fusion of vessels, resulting in atypical shunts, so-called arteriovenous malformations (AVM). Currently, the mechanism behind AVM formation remains unclear and treatment options are fairly limited. Mammalian AV differentiation
-
Hypertension-Associated Expenditures Among Privately Insured US Adults in 2021. Hypertension (IF 6.9) Pub Date : 2024-09-10 Ashutosh Kumar,Siran He,Lisa M Pollack,Jun Soo Lee,Omoye Imoisili,Yu Wang,Lyudmyla Kompaniyets,Feijun Luo,Sandra L Jackson
BACKGROUND There are no recent estimates for hypertension-associated medical expenditures. This study aims to estimate hypertension-associated incremental medical expenditures among privately insured US adults. METHODS We conducted a retrospective cohort study using IQVIA's Ambulatory Electronic Medical Records-US data set linked with PharMetrics Plus claims data. Among privately insured adults aged
-
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation. Eur. Heart J. (IF 37.6) Pub Date : 2024-09-09 Khawaja M Talha,Marco Metra,Javed Butler
-
Management of aortic disease in children with FBN1-related Marfan syndrome Eur. Heart J. (IF 37.6) Pub Date : 2024-09-09 Laura Muiño-Mosquera, Elena Cervi, Katya De Groote, Wendy Dewals, Zina Fejzic, Kalliopi Kazamia, Sujeev Mathur, Olivier Milleron, Thomas S Mir, Dorte G Nielsen, Michal Odermarsky, Anna Sabate-Rotes, Annelies van der Hulst, Irene Valenzuela, Guillaume Jondeau
Marfan syndrome (MFS) is a hereditary connective tissue disorder with an estimated prevalence of 1:5000–1:10 000 individuals. It is a pleiotropic disease characterized by specific ocular, cardiovascular, and skeletal features. The most common cardiovascular complication is aortic root dilatation which untreated can lead to life-threatening aortic root dissection, mainly occurring in adult patients
-
Genetic and Pharmacologic Inhibition of JAK1/2 Antagonizes Cardiac Fibrosis. Circulation (IF 35.5) Pub Date : 2024-09-09 Qinghang Meng,Bo Yang,Yan Qiao,Yingxin Wu,Jie Chen,Xinhua Lin,Jeffery D Molkentin
-
Quantifying Longevity After Myocardial Infarction: What Is Lost and What Is Gained. Circulation (IF 35.5) Pub Date : 2024-09-09 Neel M Butala,Emily M Bucholz
-
Noninferiority Clinical Trials: Overview for the Clinical Cardiologist. Circulation (IF 35.5) Pub Date : 2024-09-09 Sabina A Murphy,Andrea Bellavia
-
Transcatheter Aortic Valve Implantation: Two Decades of a Revolutionary and Ongoing Odyssey. Circulation (IF 35.5) Pub Date : 2024-09-09 Alain Cribier,Hélène Eltchaninoff
-
Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach. Circulation (IF 35.5) Pub Date : 2024-09-09 Satish Singh,Pardeep Kumar,Yogendra S Padwad,Farouc A Jaffer,Guy L Reed
Venous thrombosis and pulmonary embolism (venous thromboembolism) are important causes of morbidity and mortality worldwide. In patients with venous thromboembolism, thrombi obstruct blood vessels and resist physiological dissolution (fibrinolysis), which can be life threatening and cause chronic complications. Plasminogen activator therapy, which was developed >50 years ago, is effective in dissolving
-
Temporal Trends in Prevalence of Bicuspid Aortic Valves in Patients Undergoing Surgical Aortic Valve Replacement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2024-09-09 Faysal Massad,Shriya N Bavishi,Christopher G Scott,Susan L Holtegaard,Juan A Crestanello,Melanie C Bois,Patricia A Pellikka
-
Asymmetrical Expansion of Balloon-Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamic and Clinical Outcomes. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2024-09-09 Annette Maznyczka,Dierik Heg,Daijiro Tomii,Masaaki Nakase,Pernille Steen Baekke,Jonas Lanz,Stefan Stortecky,David Reineke,Stephan Windecker,Thomas Pilgrim
BACKGROUND Asymmetrical expansion of transcatheter heart valves (THVs), manifesting as stent frame deformation, is an occasional fluoroscopic finding in transcatheter aortic valve replacement (TAVR). OBJECTIVES The aim of this study was to investigate the impact of asymmetrical expansion of balloon-expandable THVs on hemodynamic valve performance and clinical outcomes. METHODS In a prospective registry
-
Volume-Adjusted Annular Sizing of Balloon-Expandable Transcatheter Heart Valves for Severe Bicuspid Aortic Valve Stenosis. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2024-09-09 So-Min Lim,Jung-Min Ahn,Do-Yoon Kang,Ha Hye Jo,Joong Min Lee,Young-Sun Park,Duk-Woo Park,Seung-Jung Park
-
The Feasibility of Cardiac Snare Retrieval of Embolized Cyanoacrylate Glue. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2024-09-09 Bryan P Traynor,Ahmad Alli,Melissa Y Y Moey,Loai Almazroa,Gianluigi Bisleri,Neil P Fam,Sami Alnasser